Search

everythinglearnresearchcommunity

for

Search:↓

ATP increases melanin production in skin after UV exposure, with the P2X7 receptor being crucial for this process.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

The T-zone on the face has more androgen receptors and produces more oil than the U-zone.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Estrogen receptors may not affect mouse hair growth as previously thought, and oxybenzone in sunscreen is stable in sunlight.

The glucocorticoid receptor helps protect skin from tumors and other issues.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Androgen receptor degrader drugs may be a promising future treatment for hair loss.

Mast cells and the CB1 receptor may be key in causing IgA vasculitis.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Researchers found that the Leptin receptor is a consistent marker for hair follicle dermal cells, which may help future hair research.

Human hair follicles have a scent receptor that can influence hair growth.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Higher androgen receptor levels in bald areas may cause hair loss, while estrogen receptors have less impact.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Vitamin D and its receptor regulate skin functions like cell growth, immunity, hair cycle, and tumor prevention.

A genetic defect in vitamin D receptors causes severe rickets and hair loss in children, but some heal as they age.

Targeting the Smoothened receptor shows promise for treating certain cancers.